Alterity Share Price
NASDAQ: ATHE | Others$1.76
-$0.14 (-7.11%) Last updated on 19 Nov, 2026 | 01:05 ISTAlterity Stock Performance
Alterity Share Price Chart
$0.00$0.00
L
H
Corporate Actions
About Alterity
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment: research and development into Parkinsonian and other neurodegenerative disorders.
Alterity Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.47 | $1.90 | -15.56% |
Oct 2026 | $3.36 | $2.25 | -40.32% |
Sep 2026 | $4.51 | $3.77 | -17.14% |
Aug 2026 | $4.70 | $4.55 | +5.32% |
Jul 2026 | $5.53 | $4.32 | -20.44% |
Jun 2026 | $4.01 | $5.43 | +35.75% |
May 2026 | $4.75 | $4.00 | -13.04% |
Apr 2026 | $3.86 | $4.60 | +25.68% |
Mar 2026 | $3.41 | $3.66 | +5.17% |
Feb 2026 | $3.49 | $3.48 | +11.90% |
Jan 2026 | $3.20 | $3.11 | -0.96% |
Dec 2025 | $3.27 | $3.14 | -17.04% |